$WAL

Kennedy Barbara sold (to issuer) $21K of WAL

Kennedy Barbara (Chief Human Resources Officer) sold (to issuer) 257 shares of WESTERN ALLIANCE BANCORPORATION (WAL) at $82.32 across 3 trades on 2026-08-15.

Original reporting
SEC EDGAR · Kennedy Barbara
Published Aug 18, 2026, 8:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 8:53 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$WAL
Neutral
high confidence
Mentioned
$WAL
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$WALNeutralLow
01

Why it matters

The disclosure updates the record of insider activity but does not introduce new company-specific fundamentals, guidance, or regulatory developments.

02

Market read

Traders may note the insider sale size and timing, but the filing lacks new fundamental catalysts.

03

What to watch

Form 4 sales to the issuer can be mechanical (e.g., buyback participation or plan-related mechanics) and may not reflect a view on bank performance.

Relevance 3/10Novelty 3/10Timing: filed after-hours on 2026-08-18, reflecting trades dated 2026-08-15

Background

The article is a SEC Form 4 insider transaction disclosure for Western Alliance Bancorporation.

Company-level read

Ticker impact

$WALNeutralHigh confidence
Context

Western Alliance Bancorporation disclosed an insider sale to the issuer by its CHRO, Kennedy Barbara, totaling $21,156.24 at $82.32/share.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a sale to the issuer (buyback participation style) with no 10b5-1 plan and a modest dollar value relative to typical market impact, providing no new operating or regulatory information.

Market effects

Insider selling activity in a regional bank is not, by itself, a sector-wide catalyst.

No specific regional contagion signal is provided beyond one issuer’s insider transaction.

No global macro or cross-border linkage is indicated.

Counterpoint

Because the CHRO sold without a stated 10b5-1 plan, some traders may interpret it as a stronger personal liquidity signal, potentially increasing short-term skepticism.

Key entities

  • Western Alliance Bancorporation

    Subject of the Form 4 insider transaction disclosure.

  • Kennedy Barbara

    Chief Human Resources Officer who sold shares to the issuer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WALMed

Stephens cuts Western Alliance stock price target on NII outlook

Stephens reduced its price target on Western Alliance Bancorporation (WAL) to $88 from $94, citing lower net interest income expectations. The bank's Q3 earnings per share missed estimates at $2.32, but its credit profile improved. WAL returned $212.5M to shareholders over the past year and expects $60M in Q4 buybacks. Stephens also lowered its 2027 and 2028 EPS estimates. Despite a Q3 2026 earnings beat, WAL stock trades below its 52-week high.

$WALHighAI 8/10

Western Alliance Bancorp (WAL) (Q3 2026) Earnings Call Highlights: Deposit Optimization

Western Alliance Bancorp (WAL) reported Q3 2026 earnings with nonaccrual loans declining 14% and deposit costs reduced by $14 million. PPNR grew 6% YoY to $419 million, and EPS increased 7.5% to $2.45. However, total deposits declined $119 million, and loan growth outlook was revised lower. Net interest income growth outlook was reduced to 11%-12%. Share repurchases totaled $92 million. Management discussed deposit optimization, loan growth strategy, and expense outlook.

$WALMed

Western Alliance Bancorp (WAL) Reports Solid Q3 2026 Results wit

Western Alliance Bancorp (WAL) reported Q3 2026 results with a 6% YoY increase in pre-provision net revenue to $419M and a 7.5% rise in EPS to $2.45. The bank improved asset quality, reduced nonaccrual loans by 14%, and repurchased $92M in shares. WAL's P/S ratio is 2.12x, below its historical median of 3.9x, indicating cautious market growth expectations. The company's GF Score is 88/100, reflecting strong growth and profitability but weak financial strength.

$WALHighAI 8/10

Western Alliance Bancorp (WAL) (Q3 2026) Earnings Call Highlight

Western Alliance Bancorp (WAL) reported Q3 2026 earnings with net revenue up $76M YoY. Net interest income rose 8% YoY to $808M, while noninterest income increased 10% YoY to $207M. Net income grew 6% YoY to $277M, with EPS up 7.5% to $2.45. Deposit costs decreased $14M QoQ, and nonaccrual loans fell 14% QoQ. Loan growth guidance was revised lower by $1B, and deposit growth outlook was reduced to $3.5B-$4B. Share repurchases totaled $92.1M in Q3.

$WALHighAI 8/10

Western Alliance (WAL) Q3 2026 Earnings Call Transcript

Western Alliance (WAL) reported Q3 2026 earnings with PPNR up 6% YoY to $419M, EPS up 7.5% to $2.45, and net income up 6% to $277M. The company completed $4.5B in deposit optimization, reducing costs, and repurchased $92M in shares. HFI loans grew 5.4% QoQ, and ROA increased to 15.5%. Management expects further deposit cost reductions in Q4 and remains on track to meet medium-term goals.

$WALMedAI 8/10

Western Alliance Bancorporation Q3 Earnings Call Highlights

Western Alliance Bancorporation (WAL) reported Q3 earnings with deposit optimization driving margin expansion. Deposit costs fell $14M, contributing to a 10-basis-point increase in adjusted net interest margin. Total deposits were $81.8B, with commercial banking deposits rising to 34% of total. Earnings per share increased 7.5% YoY to $2.45. Management expects deposit costs to decline further but anticipates a seasonal NIM headwind.